Markets:

Overview

News

Currencies

International

Treasuries

Tempus AI, Inc. - Class A Common Stock (NQ:TEM)

50.84 -3.23 (-5.96%)

Streaming Delayed Price Updated: 10:24 AM EDT, May 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Tempus AI, Inc. - Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

17 18 Next >

Tempus AI (TEM) Q1 2026 Earnings Transcript ↗

May 05, 2026

Tempus AI (TEM) Q1 2026 Earnings Transcript

Via The Motley Fool

Topics Artificial Intelligence

Tempus AI Inc. (NASDAQ:TEM) Tumbles After Q1 Revenue Miss Despite EPS Beat and Raised Guidance ↗

May 05, 2026

Via Chartmill

Topics Artificial Intelligence

Tempus Reports First Quarter 2026 Results

May 05, 2026

From Tempus AI, Inc.

Via Business Wire

Tempus to Host Inaugural Investor Day on May 29, 2026

April 29, 2026

From Tempus AI, Inc.

Via Business Wire

Tempus AI Inc (NASDAQ:TEM) Reports Strong Q4 Revenue Beat and First Positive Adjusted EBITDA ↗

February 24, 2026

Via Chartmill

Topics Artificial Intelligence

Tempus Named to TIME's 10 Most Influential Health and Life Science Companies of 2026

April 28, 2026

From Tempus AI, Inc.

Via Business Wire

Tempus and USC Announce Strategic Collaboration to Accelerate AI-Driven Precision Medicine

April 23, 2026

From Tempus AI, Inc.

Via Business Wire

Tempus to Report First Quarter 2026 Financial Results on May 5

April 21, 2026

From Tempus AI, Inc.

Via Business Wire

Tempus and Medtronic Announce ALERT Trial Results Showing AI-Driven EHR Notifications Improve Treatment for Significant Valvular Heart Disease

April 01, 2026

From Tempus AI, Inc.

Via Business Wire

2 AI Healthcare Stocks to Buy Right Now ↗

March 31, 2026

The convergence of two already fantastic industries is creating an incredible opportunity.

Via The Motley Fool

Topics Artificial Intelligence

Want $1 Million in Retirement? Invest $10,000 in These 2 AI Stocks and Hold for 10 Years. ↗

March 21, 2026

AI is rewriting drug discovery. Recursion Pharmaceuticals and Tempus AI might be the platforms that turn early investors into millionaires.

Via The Motley Fool

Topics Artificial Intelligence

Tempus and Blood Cancer United® Announce Collaboration to Develop One Of the Largest Pediatric Acute Myeloid Leukemia Real-World Data Registries

March 17, 2026

From Tempus AI, Inc.

Via Business Wire

Tempus Announces Study Highlighting the Role of Advanced Genomic Profiling Features in Identifying Clinically Actionable Findings

March 11, 2026

From Tempus AI, Inc.

Via Business Wire

Tempus Announces Strategic Collaboration Agreement with Merck to Accelerate AI-Driven Precision Medicine

March 03, 2026

From Tempus AI, Inc.

Via Business Wire

MarketBeat Week in Review – 02/23 - 02/27 ↗

February 28, 2026

Sometimes the best offense is a good defense. That’s what investors seem to be feeling. Technology stocks continue to be under pressure, and that money is flowing into traditionally defensive assets...

Via MarketBeat

After a Near 50% Drop, Tempus AI Could Be Ripe for a Rebound ↗

February 27, 2026

Via MarketBeat

Topics Artificial Intelligence

Tempus to Participate in the Morgan Stanley Technology, Media & Telecom Conference

February 26, 2026

From Tempus AI, Inc.

Via Business Wire

Tempus AI Sold Off After a Beat—But the Rebound Case Is Building ↗

February 25, 2026

Via MarketBeat

Topics Artificial Intelligence

Tempus Reports Fourth Quarter and Full Year 2025 Results

February 24, 2026

From Tempus AI, Inc.

Via Business Wire

Tempus Announces Novel Pan-Cancer HRD-RNA Algorithm

February 18, 2026

From Tempus AI, Inc.

Via Business Wire

Tempus Announces Collaboration with Median Technologies to Integrate AI-Powered Lung Cancer Screening into the Pixel Platform

February 12, 2026

From Tempus AI, Inc.

Via Business Wire

Tempus to Report Fourth Quarter and Full Year 2025 Financial Results on February 24

February 10, 2026

From Tempus AI, Inc.

Via Business Wire

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought ↗

February 05, 2026

The widely followed growth investor keeps making moves.

Via The Motley Fool

Topics Artificial Intelligence Economy

Ambry’s Contributions to MAVEs Support Thousands of Patient Reclassifications and Expand to New Genes

February 04, 2026

From Ambry Genetics

Via Business Wire

Ambry Genetics Announces One Millionth Test Leveraging RNA to Improve Diagnostic Accuracy and Yield

February 02, 2026

From Ambry Genetics

Via Business Wire

Here Are Congresswoman Nancy Pelosi's Initial Stock Moves in 2026: They Include Nvidia, Alphabet, and Amazon Stocks, and Others ↗

February 01, 2026

The main theme in Nancy Pelosi's stock investments remains "betting big on AI."

Via The Motley Fool

Topics Bonds

Tempus Reveals Its AI-Driven IPS Test More Accurately Predicts Immunotherapy Benefit Compared to Conventional Biomarkers

January 27, 2026

From Tempus AI, Inc.

Via Business Wire

Pelosi’s Bullish 2026 Buy List: AI, Power & Dividends ↗

January 26, 2026

Via MarketBeat

Topics Artificial Intelligence

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought ↗

January 22, 2026

Ark Invest is beating the market again in 2026, and the iconic growth investor wants to keep it that way.

Via The Motley Fool

Topics Artificial Intelligence ETFs

Tempus Announces the Launch of Paige Predict

January 21, 2026

From Tempus AI, Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9

...

17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.